These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19060352)

  • 21. Interstitial pneumonitis during imatinib therapy.
    Isshiki I; Yamaguchi K; Okamoto S
    Br J Haematol; 2004 May; 125(4):420. PubMed ID: 15142112
    [No Abstract]   [Full Text] [Related]  

  • 22. An acute hepatitis resembling autoimmune hepatitis occurring during imatinib therapy in a gastrointestinal stromal tumor patient.
    Aliberti S; Grignani G; Allione P; Fizzotti M; Galatola G; Pisacane A; Aglietta M
    Am J Clin Oncol; 2009 Dec; 32(6):640-1. PubMed ID: 19955903
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of extensive disease].
    Ploner F; Eisterer W
    Wien Med Wochenschr; 2009; 159(15-16):403-7. PubMed ID: 19696985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-induced pneumonitis associated with imatinib mesylate in a patient with idiopathic pulmonary fibrosis.
    Yamasawa H; Sugiyama Y; Bando M; Ohno S
    Respiration; 2008; 75(3):350-4. PubMed ID: 16449804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imatinib-induced bone edema: case report and review of literature.
    dos Santos LV; Lima JP; Abdalla KC; Bragagnoli AC; Santos FA; dos Anjos Jácome A; Porto FE
    J Natl Compr Canc Netw; 2013 Oct; 11(10):1187-91. PubMed ID: 24142819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corticosteroid-responsive interstitial pneumonitis related to imantinib mesylate with successful rechallenge, and potential causative mechanisms.
    Grimison P; Goldstein D; Schneeweiss J; Murray N
    Intern Med J; 2005 Feb; 35(2):136-7. PubMed ID: 15705148
    [No Abstract]   [Full Text] [Related]  

  • 27. Soft tissue calcification secondary to imatinib mesylate in a patient with gastrointestinal stromal tumor.
    Enck RE; Abushahin F; Bossaer JB
    J Oncol Pharm Pract; 2014 Apr; 20(2):137-40. PubMed ID: 23676509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concurrent male gynecomastia and testicular hydrocele after imatinib mesylate treatment of a gastrointestinal stromal tumor.
    Kim H; Chang HM; Ryu MH; Kim TW; Sohn HJ; Kim SE; Kang HJ; Park S; Lee JS; Kang YK
    J Korean Med Sci; 2005 Jun; 20(3):512-5. PubMed ID: 15953881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sunitinib for imatinib-resistant GIST.
    Joensuu H
    Lancet; 2006 Oct; 368(9544):1303-4. PubMed ID: 17046443
    [No Abstract]   [Full Text] [Related]  

  • 30. Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma.
    Goodman VL; Rock EP; Dagher R; Ramchandani RP; Abraham S; Gobburu JV; Booth BP; Verbois SL; Morse DE; Liang CY; Chidambaram N; Jiang JX; Tang S; Mahjoob K; Justice R; Pazdur R
    Clin Cancer Res; 2007 Mar; 13(5):1367-73. PubMed ID: 17332278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transient respiratory failure possibly associated to imatinib.
    Lengerke C; Brümmendorf T; Herrlinger U; Horger M; Kanz L; Hartmann JT
    Invest New Drugs; 2005 Mar; 23(2):137-8. PubMed ID: 15744589
    [No Abstract]   [Full Text] [Related]  

  • 32. [Drug-induced pneumonia that may have been caused by imatinib mesylate administered for gastrointestinal stromal tumor].
    Iritani E; Kondo M; Kanemura T; Hara Y; Tagaya E; Tamaoki J; Nagai A
    Nihon Kokyuki Gakkai Zasshi; 2007 Jul; 45(7):577-81. PubMed ID: 17682471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary gastrointestinal stromal tumor of the liver treated with sequential therapy.
    Lin XK; Zhang Q; Yang WL; Shou CH; Liu XS; Sun JY; Yu JR
    World J Gastroenterol; 2015 Feb; 21(8):2573-6. PubMed ID: 25741171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Irreversible imatinib-induced pneumonitis following long-term imatinib administration.
    Seki N; Ito A; Watanabe K; Shibakuki R; Seto T; Uematsu K; Mine T; Eguchi K
    Intern Med; 2007; 46(23):1941-2. PubMed ID: 18057772
    [No Abstract]   [Full Text] [Related]  

  • 35. Early onset imatinib mesylate-induced hepatotoxicity in a patient with gastrointestinal stromal tumors.
    Yachoui R
    Am J Ther; 2014; 21(5):e148-50. PubMed ID: 23567788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in the treatment of gastrointestinal stromal tumor.
    D'Adamo D
    Adv Ther; 2009 Sep; 26(9):826-37. PubMed ID: 19802531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imatinib induced pyoderma gangrenosum.
    Pinato DJ; Sharma R
    J Postgrad Med; 2013; 59(3):244-5. PubMed ID: 24029213
    [No Abstract]   [Full Text] [Related]  

  • 38. Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib.
    Janeway KA; Albritton KH; Van Den Abbeele AD; D'Amato GZ; Pedrazzoli P; Siena S; Picus J; Butrynski JE; Schlemmer M; Heinrich MC; Demetri GD
    Pediatr Blood Cancer; 2009 Jul; 52(7):767-71. PubMed ID: 19326424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors.
    Demetri GD; von Mehren M; Antonescu CR; DeMatteo RP; Ganjoo KN; Maki RG; Pisters PW; Raut CP; Riedel RF; Schuetze S; Sundar HM; Trent JC; Wayne JD
    J Natl Compr Canc Netw; 2010 Apr; 8 Suppl 2(0 2):S1-41; quiz S42-4. PubMed ID: 20457867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Gastrointestinal stromal tumors. An update].
    Bórquez Ma P; Neveu C R
    Rev Med Chil; 2008 Jul; 136(7):921-9. PubMed ID: 18949171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.